Article
San Francisco - Two large phase III studies involving 15 percent azelaic gel (Finacea) for the treatment of rosacea each resulted in more than a 50-percent reduction in the number of lesions.
When and How to Employ the Buy and Bill Model
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Insights from a Dermatologist with Urticaria
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
The Weekly Roundup: January 13 – 17
Adjunctive Dermocosmetic Therapy Reduces Sensitivity and Improves Quality of Life for Patients with Acne
Secukinumab Demonstrates Long-Term Safety and Efficacy in Pediatric Patients with GPP
Top 5 Articles of the Week: January 12-17